ArticleFrontline gastroenterology2023

Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapy.

Dipesh Chauhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.